However, 17β-estradiol (E2) and tamoxifen have both been shown to regulate PTHrP expression in breast cancer cells (147), suggesting an association between estrogen receptor signaling and PTHrP during tumorigenesis. This evidence concerns the gene ESR1 and breast carcinoma.